Skip to main content Help with accessibility Skip to main navigation

BROLUCIZUMAB solution for injection (Beovu®▼) for treating wet age-related macular degeneration

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 29 - Dec - 2026
Body System:
Red
BROLUCIZUMAB solution for injection (Beovu®▼) for treating wet age-related macular degeneration

The Pan Mersey Area Prescribing Committee recommends the prescribing of BROLUCIZUMAB solution for injection (Beovu®▼), by specialists only for treating wet age-related macular degeneration in line with NICE TA672.